参考文献/References:
[1] Marks LB,Munley MT,Bentel GC,et al.Physical and biological predictors of changes in whole-lung function following thoracic irradiation.Int J Radiat Oncol Biol Phys,1997,39(3):563-570.
[2] Kwa SL,Lebesque JV,Theuws JC,et al.Radiation pneumonitis as a function of mean lung dose:an analysis of pooled data of 540 patients.Int J Radiat Oncol Biol Phys,1998,42(1):1-9.
[3] Fu XL Huang H,Bentel G,et al.Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters Ⅴ (30) and transforming growth factor beta.Int J Radiat Oncol Biol Phys,2001,50(4):899-908.
[4] Graham MV,Pajak TE,Herskovic AM,et al.Phase Ⅰ/Ⅱ study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the radiation therapy oncology group (RTOG 83-12):long-term results.Int J Radiat Oncol Biol Phys,1995,31(4):819-825.
[5] Komaki R,Lee JS,Milas L,et al.Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer:report of a randomized comparative trial.Int J Radiat Oncol Biol Phys,2004,58(5):1369-1377.
[6] Delaunois LM.Mechanisms in pulmonary toxicology.Clin Chest Med,2004,25(1):1-14.
[7] Vujaskovic Z,Groen HJ.TGF-beta,radiation-induced pulmonary injury and lung cancer.Int J Radiat Biol,2000,76(4):511-516.
[8] 高春芳.纤维化疾病的基础与临床.上海:上海科学技术出版杜,2004:90-99.
[9] Ao X,Zhao L,Davis MA,et al.Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice.J Hematol Oncol,2009,2:6.
[10] Yang K,Palm J,König J,et al.Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.Int J Radiat Biol,2007,83(10):665-676.
[11] Westermann W,Schobl R,Ricber EP,et al.Th2 cells as effectors inpostirradiation pulmonary damage preceding fibrosis in the rat.Int J Radiat Biol,1999,75(5):629-638.
[12] Ghosh SN,Zhang R,Fish BL,et al.Renin-angiotensin system suppression mitigates experimental radiation pneumonitis.Int J Radiat Oncol Biol Phys,2009,75(5):1528-1536.
[13] Rossi SE,Erasmus JJ,McAdams HP,et al.Pulmonary drug toxicity:radiologic and pathologic manifestations.Radiographics,2000,20(5):1245-1259.
[14] Erasmus JJ,McAdams HP,Rossi SE.High-resolution CT of drug induced lung disease.Radiol Clin North Am,2002,40(1):61-72.
[15] Movsss B,Raffin TA,Epstein AH,et al.Pulmonary radiation injury.Chest,1997,111(4):1061-1076.
[16] Trott KR,Herrmann T,Kasper M.Target cells in radiation pneumopathy.Int J Radiat Oncol Biol Phys,2004,58(2):463-469.
[17] Pang QS,Wang P,Wang J,et al.Basic research of the relationship between irradiation dose and volume in radiation-induced pulmonary injury.Chin Med J(Engl),2009,122(16):1929-1934.
[18] Müller G,Kiricuta IC,Stiess J,et al.Radiation pneumonitis and pulmonary fibrosis after the CT-planned radiotherapy of bronchial carcinoma.Strablenther Onkol,1994,170(7):400-407.
[19] Marks LB.Dosimetric predictors of radiation-induced lung injury.Int J Rediat Oncol Biol Phys,2002,54(2):313-316.
[20] Willner J,Jost A,Baier K,et al.A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.Strahlenther Onkol,2003,179(8):548-556.
[21] 程文芳,钱飞宇.肺癌放疗与放射性肺炎的研究.实用肿瘤学杂志,2000,14(4):274-275.
[22] Hemando ML,Marks LB,Bentel GC,et al.Radiation-induced pulmonary toxicity:a dose-volume histogram analysis in 201 patients with lung cancer.Int J Radiat Oncol Biol Phys,2001,51(3):650-659.
[23] Roach M 3rd,Gandara DR,Yuo HS,et al.Radiation pneumonitis following combined modality therapy for lung cancer:analysis of prognostic factors.J Clin Oncol,1995,13(10):2606-2612.
[24] Rancati T,Ceresoli GL,Gagliardi G,et al.Factors predicting radiation pneumonitis in lung cancer patients:a retrospective study.Radiother Oncol,2003,67(3):275-283.
[25] Taghian AG,Assaad SI,Niemierko A,et al.Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel.J Natl Cancer Iast,2001,93(23):1806-1811.
[26] Marks LB,Fan M,Clough R,et al.Radiation-induced pulmonary injury:symptomatic versus subclinical endpoints.Iht J Radiat Biol,2000,76(4):469-475.
[27] Skoczylas JZ,Bentzen SM,Overgaard M,et al.Time course of radiological lung density changes after postmastectomy radiotherapy.Acta Oncol,2000,39(2):181-187.
[28] Koenig TR,Munden RF,Erasmus JJ,et al.Radiation injury of the lung after three-dimensional conformal radiation therapy.AJR Am J Roentgenol,2002,178(6):1383-1388.
[29] Song H,Yu JM,Kong FM,et al.[18F]2-fluoro-2-deoxyglucose positron emission tomography/computed tomography in predicting radiation pneumonitis.Chin Med J (Engl),2009,122(11):1311-1315.
[30] Theuws JC,Seppenwoolde Y,Kwa SL,et al.Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer.Int J Radiat Oncol Biol Plhys,2000,47(5):1201-1208.
[31] Woel RT,Munley MT,Hollis D,et al.The time course of radiation therapy-induced reductions in regional perfusion:a prospective study with >5 years of follow-up.Int J Radiat Oncol Biol Phys,2002,52(1):58-67.
[32] Moulder JE,Fish BL,Cohen EP.Angiotensin Ⅱ receptor antagonists in the treatment and prevention of radiation nephropathy.Int J Radiat Biol,1998,73(4):415-421.
[33] Li M,Abdollahi A,Gr(o)ne HJ,et al.Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model.Radiat Oncol,2009,4:66.
相似文献/References:
[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[3]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[4]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[5]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[6]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[7]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[8]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[9]段永璇,邹晓艳,段秀梅,等.数据解析在肿瘤放射治疗中的应用[J].国际放射医学核医学杂志,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
Duan Yongxuan,Zou Xiaoyan,Duan Xiumei,et al.Data analysis in the field of tumor radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
[10]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
[11]王月英,吴红英,李德冠,等.小鼠不同肿瘤模型对放化疗敏感性的研究[J].国际放射医学核医学杂志,2012,36(5):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
WANG Yue-ying,WU Hong-ying,LI De-guan,et al.The radiation sensitivities of different mice tumor model to radiotherapy and chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
[12]王政,郭阳,姜炜.嗅神经母细胞瘤的诊断与治疗进展[J].国际放射医学核医学杂志,2011,35(4):241.[doi:10.3760/cma.j.issn.1673-4114.2011.04.012]
WANG Zheng,GUO Yang,JIANG Wei.Progress of diagnosis and treatment of esthesioneuroblastoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):241.[doi:10.3760/cma.j.issn.1673-4114.2011.04.012]
[13]汪俊剑,黄少祥.化疗和放化疗同步治疗局部晚期非小细胞肺癌临床观察[J].国际放射医学核医学杂志,2008,32(5):317.
WANG Jun-jian,HUANG Shao-xiang.Clinical observation of radiotherapy concurrently combined with chemotherapy for local advanced nonsmall cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):317.
[14]宋少莉,黄钢.18F-氟脱氧葡萄糖PET监测实体瘤放化疗疗效的应用进展[J].国际放射医学核医学杂志,2007,31(5):284.
SONG Shao-Li,HUANG Gang.The development of monitoring chemotherapy and radiotherapy of solid tumor by 18F-fluorodeoxyglucose PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):284.
[15]杨明威,王孝深,王凡,等.顺铂单周与三周方案同期联合调强放射治疗局部晚期鼻咽癌的不良反应与疗效的比较[J].国际放射医学核医学杂志,2018,(5):397.[doi:10.3760/cma.j.issn.1673-4114.2018.05.002]
Yang Mingwei,Wang Xiaoshen,Wang Fan,et al.Comparison of toxicities and treatment outcome of weekly and triweekly cisplatin concurrent with intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(4):397.[doi:10.3760/cma.j.issn.1673-4114.2018.05.002]